Stress Management for Irritable Bowel Syndrome
| Status: | Completed |
|---|---|
| Conditions: | Irritable Bowel Syndrome (IBS) |
| Therapuetic Areas: | Gastroenterology |
| Healthy: | No |
| Age Range: | 18 - 70 |
| Updated: | 4/13/2015 |
| Start Date: | June 2013 |
| End Date: | March 2015 |
| Contact: | Elyse Thakur, M.A. |
| Email: | healthlab@wayne.edu |
| Phone: | 313-577-2773 |
The primary goal of this study is to test the efficacy of emotional awareness and expression
training (EAET), a novel emotional processing intervention that the investigators have
developed, for people with IBS. In this randomized, controlled trial, the investigators will
compare EAET to a standard intervention that teaches the conceptually opposite
approach—relaxation training (RT)—and test how both of these interventions compare to a
wait-list control condition. The investigators hypothesize that individuals in the EAET
group will demonstrate greater improvement in their IBS symptom severity, psychological
functioning, quality of life, and health care utilization at 4 and 12-week follow-up time
points, compared to individuals in the wait-list control group. It is also expected that
both of the active interventions (EAET and RT) will be more efficacious than the wait-list
control condition.
training (EAET), a novel emotional processing intervention that the investigators have
developed, for people with IBS. In this randomized, controlled trial, the investigators will
compare EAET to a standard intervention that teaches the conceptually opposite
approach—relaxation training (RT)—and test how both of these interventions compare to a
wait-list control condition. The investigators hypothesize that individuals in the EAET
group will demonstrate greater improvement in their IBS symptom severity, psychological
functioning, quality of life, and health care utilization at 4 and 12-week follow-up time
points, compared to individuals in the wait-list control group. It is also expected that
both of the active interventions (EAET and RT) will be more efficacious than the wait-list
control condition.
Inclusion Criteria:
To be eligible to participate, individuals must meet the Rome III criteria for IBS. That
is, they must report that they have had:
- recurrent abdominal pain or discomfort, or
- a change in stool frequency or form,
- at least three days per month, in the last three months, and
- that they have been given this diagnosis by a physician. They must also report having
pain and discomfort of at least two days per week at time of screening.
Exclusion Criteria:
- Individuals who report having post-infectious IBS,
- organic gastrointestinal diseases (e.g., inflammatory bowel disease),
immunodeficiency,
- a current psychotic disorder,
- drug or alcohol dependence within the past two years, and
- those who are unable to communicate in English will be excluded.
We found this trial at
1
site
Wayne State University Founded in 1868, Wayne State University is a nationally recognized metropolitan research...
Click here to add this to my saved trials
